Literature DB >> 23315175

Effect of Y220C mutation on p53 and its rescue mechanism: a computer chemistry approach.

Shah Md Abdur Rauf1, Akira Endou, Hiromitsu Takaba, Akira Miyamoto.   

Abstract

Mutation causes inactivation of 'p53' tumor suppressor protein in almost fifty percent of cancers in humans. Outside the DNA-binding surface of p53, Y220C is the most common cancerous mutation. Previous studies have shown that a surface cavity is created by this mutation which destabilizes p53. PhiKan083, a carbazole derivative capable of binding with that cavity, and slows down its thermal denaturation rate. We investigated, theoretically, on mechanisms of structural stability loss due to Y220C mutation and mechanisms of stability restoration by PhiKan083 at the atomic level. From this study it is found that in Tp53C, Tyr220 has five electrostatic interactions with residues Val 147, Prol51, Pro153 and Pro223 located on S3/S4 loop and S7/S8 loop. The S7/S8 loop is stabilized by these electrostatic interactions. Due to the Y220C mutation all these electrostatic interactions are lost. As a result the structural fluctuation occurs at S7/S8 loop, and the loop is displaced from its original position after 6 ns MD simulation. When PhiKan083 is present (inserted) at the mutation site it provides five electrostatic interactions with Pro155, Glu221 and Thr230, and two hydrogen bonds with Leu145 and Asp228, respectively. These interactions provided by Pkikan083 stabilized the S7/S8 loop, and as a result it couldn't be displaced. Our results showed that due to Y220C mutation p53 became destabilized through structural fluctuations surrounding the mutation site. When PhiKan083 is present at the Y220C mutation site (in 2vuk), it provides electrostatic and hydrogen bonding interactions among residue-220, its neighboring residues and PhiKan08. These interactions give additional stability to Y220C mutant p53, thus Y220C mutant p53 doesn't destabilize.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315175     DOI: 10.1007/s10930-012-9458-x

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  15 in total

1.  Kinetic instability of p53 core domain mutants: implications for rescue by small molecules.

Authors:  Assaf Friedler; Dmitry B Veprintsev; Lars O Hansson; Alan R Fersht
Journal:  J Biol Chem       Date:  2003-04-16       Impact factor: 5.157

Review 2.  The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability.

Authors:  L Serrano; J T Kellis; P Cann; A Matouschek; A R Fersht
Journal:  J Mol Biol       Date:  1992-04-05       Impact factor: 5.469

3.  Molecular dynamics simulations of the Bcl-2 protein to predict the structure of its unordered flexible loop domain.

Authors:  Pawan Kumar Raghav; Yogesh Kumar Verma; Gurudutta U Gangenahalli
Journal:  J Mol Model       Date:  2011-08-25       Impact factor: 1.810

4.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

5.  Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.

Authors:  A N Bullock; J Henckel; A R Fersht
Journal:  Oncogene       Date:  2000-03-02       Impact factor: 9.867

6.  The effect of R249S carcinogenic and H168R-R249S suppressor mutations on p53-DNA interaction, a multi scale computational study.

Authors:  Shah Md Abdur Rauf; Mohamed Ismael; Kamlesh Kumar Sahu; Ai Suzuki; Michihisa Koyama; Hideyuki Tsuboi; Nozomu Hatakeyama; Akira Endou; Hiromitsu Takaba; Carlos A Del Carpio; Momoji Kubo; Akira Miyamoto
Journal:  Comput Biol Med       Date:  2010-04-18       Impact factor: 4.589

7.  Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.

Authors:  Andreas C Joerger; Hwee Ching Ang; Dmitry B Veprintsev; Caroline M Blair; Alan R Fersht
Journal:  J Biol Chem       Date:  2005-02-09       Impact factor: 5.157

Review 8.  Structural biology of the tumor suppressor p53.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

9.  Transforming activity of mutant human p53 alleles.

Authors:  J M Slingerland; S Benchimol
Journal:  J Cell Physiol       Date:  1991-09       Impact factor: 6.384

Review 10.  Structure-function-rescue: the diverse nature of common p53 cancer mutants.

Authors:  A C Joerger; A R Fersht
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

View more
  6 in total

1.  FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.

Authors:  Updesh Dixit; Ashutosh K Pandey; Zhihe Liu; Sushil Kumar; Matthew B Neiditch; Kenneth M Klein; Virendra N Pandey
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

2.  Conformational transition pathway in the inhibitor binding process of human monoacylglycerol lipase.

Authors:  Huayou Chen; Rui Tian; Zhong Ni; Zhongge Zhang; Hongzhang Chen; Qi Guo; Milton H Saier; Ake Vastermark
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

Review 3.  The role of p53 in cancer drug resistance and targeted chemotherapy.

Authors:  Karin Hientz; André Mohr; Dipita Bhakta-Guha; Thomas Efferth
Journal:  Oncotarget       Date:  2017-01-31

Review 4.  Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment.

Authors:  Voon Yee-Lin; Wong Pooi-Fong; Alan Khoo Soo-Beng
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

5.  Sensitization of recombinant human tumor necrosis factor-related apoptosis-inducing ligand-resistant malignant melanomas by quercetin.

Authors:  Katherine A Turner; Jasmine M Manouchehri; Michael Kalafatis
Journal:  Melanoma Res       Date:  2018-08       Impact factor: 3.599

6.  MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53.

Authors:  Yingchao Wang; Gaoxiong Wang; Xionghong Tan; Kun Ke; Bixing Zhao; Niangmei Cheng; Yuan Dang; Naishun Liao; Fei Wang; Xiaoyuan Zheng; Qin Li; Xiaolong Liu; Jingfeng Liu
Journal:  Oncogenesis       Date:  2019-11-15       Impact factor: 7.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.